Off-Label Epinephrine Extraction for Pediatric Anaphylaxis: Risks, Benefits, and Practical Considerations

Area of Science:

• Emergency Medicine
• Allergy and Immunology
• Pediatric Care

Background:

• Anaphylaxis is a severe allergic reaction requiring immediate epinephrine treatment.
• Single-use epinephrine autoinjectors pose challenges in resource-limited settings due to delayed evacuation and potential for rebound anaphylaxis.
• Existing methods for epinephrine extraction focus on adult devices, leaving pediatric autoinjectors unaddressed.

Purpose of the Study:

• To analyze the internal mechanism, epinephrine concentration, and redosing potential of the pediatric EpiPen Jr.
• To provide instructions for safe disassembly and secondary dose extraction from the EpiPen Jr.
• To highlight risks and considerations for redosing epinephrine in pediatric populations in austere environments.

Main Methods:

• Mechanical analysis of the EpiPen Jr internal structure.
• Confirmation of epinephrine concentration in the pediatric device.
• Development of disassembly and secondary dose extraction techniques.

Main Results:

• The EpiPen Jr shares the same device structure as the adult EpiPen.
• The pediatric EpiPen Jr contains a lower epinephrine concentration (0.15 mg/0.3 mL) compared to the adult version (0.3 mg/0.3 mL).
• Instructions for mechanical disassembly and secondary dose extraction were successfully developed.

Conclusions:

• The EpiPen Jr can be mechanically disassembled for potential secondary epinephrine dosing, similar to the adult EpiPen.
• Risks of under/overdosing, cost barriers, and adverse effects associated with imprecise redosing require careful consideration.
• Further research on safety, reliability, and dosing accuracy is essential; wilderness-specific training and protocols are recommended.